Legend Biotech USA

BiotechnologySeries ASomerset, USlegendbiotech.com

Latest round

Series A

Last raised

Mar 2020

Total raised

$151M

Investors

5

About Legend Biotech USA

Founded in 2014 and based in New Jersey, US, Legend Biotech USA, Inc. is a biotech company that focuses on the development of tumor cell immunotherapy. In 2020, the company was listed on the NASDAQ. Its ticker symbol is LEGN.7 million. Ying Huang, the company's CEO, also serves as a board member of the company and Quanta Therapeutics. He has more than 9 years of R&D background in large multinational pharmaceutical companies and 12 years of experience as a biotech analyst on Wall Street.2 million. The company's R&D pipeline mainly includes small cell lung cancer DLL3, multiple myeloma BCMA and hepatocellular carcinoma GPC3, etc. It has developed CAR-T therapy targeting CD38 and BCMA for the treatment of multiple myeloma. Its products are used to treat diseases such as blood cancers and lymphomas.

Who invested in Legend Biotech USA

5 investors across 1 round

See all investors in Legend Biotech USA

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Mar 30, 2020

    Amount

    $151M

    Investors

    Locked

Questions about Legend Biotech USA

Who invested in Legend Biotech USA?

Legend Biotech USA has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Legend Biotech USA raised?

Legend Biotech USA has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Legend Biotech USA last raise money?

Legend Biotech USA's most recent round on record is a Series A, in Mar 2020.

What does Legend Biotech USA do?

Founded in 2014 and based in New Jersey, US, Legend Biotech USA, Inc.

Where is Legend Biotech USA headquartered?

Legend Biotech USA is headquartered in Somerset, US.

Which VCs invest in companies like Legend Biotech USA?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Legend Biotech USA's stage. Their profiles are linked below.

Raising like Legend Biotech USA? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.